110 related articles for article (PubMed ID: 7538728)
1. Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
Feinberg RF; Kliman HJ; Bedian V; Monzon-Bordonaba F; Menzin AW; Wang CL
Am J Obstet Gynecol; 1995 May; 172(5):1526-36. PubMed ID: 7538728
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: a caveat for cervicovaginal oncofetal fibronectin testing?
Feinberg RF; Wang CL
Am J Obstet Gynecol; 1994 Nov; 171(5):1302-8. PubMed ID: 7977538
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix interactions in early human embryos: implications for normal implantation events.
Turpeenniemi-Hujanen T; Feinberg RF; Kauppila A; Puistola U
Fertil Steril; 1995 Jul; 64(1):132-8. PubMed ID: 7789549
[TBL] [Abstract][Full Text] [Related]
4. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
5. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
7. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
8. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants.
Menzin AW; Loret de Mola JR; Bilker WB; Wheeler JE; Rubin SC; Feinberg RF
Cancer; 1998 Jan; 82(1):152-8. PubMed ID: 9428492
[TBL] [Abstract][Full Text] [Related]
9. Expression of oncofetal fibronectin in porcine conceptuses and uterus throughout gestation.
Tuo W; Bazer FW
Reprod Fertil Dev; 1996; 8(8):1207-13. PubMed ID: 8981646
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to fibronectin which inhibits extracellular matrix assembly.
Chernousov MA; Faerman AI; Frid MG; Printseva OYu ; Koteliansky VE
FEBS Lett; 1987 Jun; 217(1):124-8. PubMed ID: 2439372
[TBL] [Abstract][Full Text] [Related]
11. Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease.
Carsons S; Clausen H; Wolf J
J Rheumatol; 1994 Oct; 21(10):1888-91. PubMed ID: 7530772
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of a murine monoclonal antibody against the repetitive region of the fibronectin-binding adhesins fibronectin-binding protein A and fibronectin-binding protein B from Staphylococcus aureus.
Provenza G; Provenzano M; Visai L; Burke FM; Geoghegan JA; Stravalaci M; Gobbi M; Mazzini G; Arciola CR; Foster TJ; Speziale P
FEBS J; 2010 Nov; 277(21):4490-505. PubMed ID: 20875085
[TBL] [Abstract][Full Text] [Related]
13. Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid.
Frank HG; Huppertz B; Kertschanska S; Blanchard D; Roelcke D; Kaufmann P
Histochem Cell Biol; 1995 Oct; 104(4):317-29. PubMed ID: 8548566
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to the collagen binding domain of human plasma fibronectin.
Tarone G; Amedeo MR; Di Renzo MF; Comoglio P
Exp Cell Biol; 1984; 52(4):225-36. PubMed ID: 6203785
[TBL] [Abstract][Full Text] [Related]
15. A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.
Villa A; Lovato V; Bujak E; Wulhfard S; Pasche N; Neri D
MAbs; 2011; 3(3):264-72. PubMed ID: 21487243
[TBL] [Abstract][Full Text] [Related]
16. A unique monoclonal antibody against human plasma fibronectin, which recognizes an epitope on the surface of a subpopulation of polymorphonuclear neutrophils.
Okada M; Hitsumoto Y
Hybridoma (Larchmt); 2006 Aug; 25(4):202-8. PubMed ID: 16934016
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo.
Feinberg RF; Kliman HJ; Wang CL
J Clin Endocrinol Metab; 1994 May; 78(5):1241-8. PubMed ID: 8175984
[TBL] [Abstract][Full Text] [Related]
18. Release of oncofetal fibronectin from human placenta.
Guller S; Ma Y; Raju U; Kadner S; Thung SF; Colasacco L; Malek A; Schneider H
Placenta; 2003; 24(8-9):843-50. PubMed ID: 13129681
[TBL] [Abstract][Full Text] [Related]
19. Oncofetal fibronectin: new insight into the physiology of implantation and labor.
Dunn PA; Feinberg RF
J Obstet Gynecol Neonatal Nurs; 1996; 25(9):753-7. PubMed ID: 8951112
[TBL] [Abstract][Full Text] [Related]
20. Is oncofetal fibronectin a trophoblast glue for human implantation?
Feinberg RF; Kliman HJ; Lockwood CJ
Am J Pathol; 1991 Mar; 138(3):537-43. PubMed ID: 2000933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
